Home › Funds › Tributary Capital Management, LLC › CNMD
Tributary Capital Management, LLC position in CNMD
CONMED CORP · Health Care
Tributary Capital Management, LLC reported holding 246,588 shares of CNMD (CONMED CORP) in its Q3 2026 13F filing — a position valued at US$11.4M, representing 1.17% of its reported portfolio and ranking #47 among its reported holdings. Tributary Capital Management, LLC has disclosed CNMD holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Tributary Capital Management, LLC's CNMD position evolved
Tributary Capital Management, LLC first disclosed a stake in CNMD in Q3 2025 at 207,836 shares (US$9.8M). The position peaked in Q3 2026 at 246,588 shares, worth US$11.4M. Across 5 filings, Tributary Capital Management, LLC increased the stake 2 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 246,588 shares valued at US$11.4M — a reduction of -10,592 shares quarter over quarter.. Notable position changes include a 29% increase in Q4 2025 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2025 | 207.84K | $9.77M | New |
| Q4 2025 | 268.90K | $10.92M | Add |
| Q1 2026 | 248.98K | $8.80M | Reduce |
| Q2 2026 | 257.18K | $8.42M | Add |
| Q3 2026 | 246.59K | $11.40M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CNMD and 13F data
CNMD (CONMED CORP) is a Health Care company. 16 other funds we track also report a position in CNMD — the largest reported positions include OAKTREE CAPITAL MANAGEMENT LP (US$52.5M), Invenomic Capital Management LP (US$27.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CNMD
- OAKTREE CAPITAL MANAGEMENT LP 53.65M sh · $52.46M · Q2 2026
- Invenomic Capital Management LP 842.16K sh · $27.56M · Q2 2026
More on Tributary Capital Management, LLC
FAQ
How long has Tributary Capital Management, LLC held CNMD?
Tributary Capital Management, LLC has disclosed CNMD holdings in 5 of the last 5 reported quarters, going back to Q3 2025.
What is Tributary Capital Management, LLC's current position in CNMD?
As of Q3 2026, Tributary Capital Management, LLC holds 246.59K shares of CNMD (CONMED CORP), valued at $11.40M, representing 1.17% of its reported portfolio and ranking #47.
Has Tributary Capital Management, LLC been buying or selling CNMD?
In the latest 13F filing (Q3 2026), Tributary Capital Management, LLC reduced its position in CNMD. The position peaked in Q3 2026 at 246.59K shares.
Which other funds hold CNMD?
Other major institutional holders of CNMD include OAKTREE CAPITAL MANAGEMENT LP, Invenomic Capital Management LP, among 16 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.